In addition, the results showed that AKR1B1, AKR1C2, and AKR1C3, which were also members of the aldosterone reductase family, were also involved in the mechanism of the resistance of glioblastoma to adriamycin. This evidence concerns the gene AKR1C3 and glioblastoma.